medicaid glp-1 coverage MCT2D ๐ข New Resource Alert! We've
Description
This flexibility helps patients stay consistent, which is one of the biggest predictors of long-term success in GLP-1-based therapy
These ongoing developments mean that patients may have even more treatment options in the future
It roughly doubles the time to reach 5 mg compared to standard titration but cuts GI side effect severity dramatically
Research suggests that GLP-1 medications may reduce this harmful fat depot as part of overall weight loss, though the mechanisms remain incompletely understood
The analysis found that the number of prescriptions for these drugs grew by more than 400% between 2019 and 2023, while spending grew by 500%
doi:10.1136/bmj-2023-076410 14
